
MAGNESIUM CITRATE
| MAGNESIUM CITRATE (mag-nes'i-um) Citrate of Magnesia, Citroma, Citro-Nesia Classifications: saline cathartic; Therapeutic: laxative Prototype: Magnesium hydroxide Pregnancy Category: B |
Availability
1.75 g/30 mL solution
Action
Hyperosmotic laxative. Promotes bowel evacuation by causing osmotic retention of fluid, which distends colon and stimulates peristaltic activity.
Therapeutic Effect
Evacuates bowels.
Uses
To evacuate bowel prior to certain surgical and diagnostic procedures and to help eliminate parasites and toxic materials after treatment with a vermifuge.
Contraindications
Severe renal impairment, renal failure; nausea, vomiting, diarrhea, abdominal pain, acute surgical abdomen; intestinal impaction, obstruction or perforation; rectal bleeding; use of solutions containing sodium bicarbonate in patients on sodium-restricted diets; children <2 y.
Cautious Use
Mild or moderate renal impairment; cardiac disease; older adults; pregnancy (category B).
Route & Dosage
| Bowel Evacuation Adult: PO 240 mL once Child: PO 26 y, 412 mL; 612 y, 50100 mL |
Administration
Oral- Give on an empty stomach with a full (240 mL) glass of water. Time dosing so that it does not interfere with sleep. Drug produces a watery or semifluid evacuation in 26 h.
- Chill solution by pouring it over ice or refrigerate it until ready to use to increase palatability.
- Be aware that once container is opened, effervescence will decrease. This does not effect the quality of preparation.
- Store at 2°30° C (36°86° F) in tightly covered containers.
Adverse Effects (≥1%)
GI: Abdominal cramps, nausea, fluid and electrolyte imbalance, hypermagnesemia (prolonged use).Interactions
Drug: May decrease effectiveness of digoxin, oral anticoagulants, phenothiazines; will decrease absorption of ciprofloxacin, tetracyclines; sodium polystyrene sulfonate will bind magnesium, decreasing its effectiveness.Pharmacokinetics
Onset: 0.52 h.Nursing Implications
Assessment & Drug Effects
- Monitor for dehydration, hypokalemia, and hyponatremia (see Appendix F) since drug may cause intense bowel evacuation.
Patient & Family Education
- Do not use for routine treatment of constipation (especially in older adult).
- Expect some degree of abdominal cramping.
Canadian drug name;
Prototype drug